Revises the Uniform Controlled Substances Act to remove specific opioid dosage requirements and update regulations in accordance with current.

This bill revises sections of the Uniform Controlled Substances Act to remove specific opioid dosage requirements and update regulations in accordance with current standards of professional practice. It repeals the Intractable Pain Treatment Act and mandates that practitioners check the patient’s prescribed controlled substance use in the prescription drug monitoring program, verify the patient’s methadone and/or buprenorphine use, refer the patient to a substance use disorder specialist, and enter into a written patient treatment agreement.

Revises the Uniform Controlled Substances Act to remove specific opioid dosage requirements and update regulations in accordance with current.

This bill revises sections of the Uniform Controlled Substances Act to remove specific opioid dosage requirements and update regulations in accordance with current standards of professional practice. It repeals the Intractable Pain Treatment Act and mandates that practitioners check the patient’s prescribed controlled substance use in the prescription drug monitoring program, verify the patient’s methadone and/or buprenorphine use, refer the patient to a substance use disorder specialist, and enter into a written patient treatment agreement.